{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T18:24:37Z","timestamp":1787423077930,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"DOI":"10.1007\/s12223-026-01577-0","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T06:02:43Z","timestamp":1787378563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phyllanthus emblica as a prebiotic modulator of the gut\u2013endocrine axis in polycystic ovary syndrome: a translational perspective on synbiotic therapeutics"],"prefix":"10.1007","author":[{"given":"Renukadevi","family":"Jeyavelkumaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimithasree","family":"Keerthivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mridula Saravanan","family":"Dhanapal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"1577_CR1","first-page":"278","volume":"138","author":"B Ahmad","year":"2021","unstructured":"Ahmad B, Hafeez N, Rauf A, Bashir S, Linfang H, Rehman M-U, Mubarak MS, Uddin MS, Bawazeer S, Shariati MA, Daglia M, Wan C, Rengasamy KRR (2021) Phyllanthus emblica: A comprehensive review of its therapeutic benefits. Suid-Afrikaanse Tydskrif Vir Plantkunde [South Afr J Botany] 138:278\u2013310","journal-title":"Suid-Afrikaanse Tydskrif Vir Plantkunde [South Afr J Botany]"},{"key":"1577_CR2","doi-asserted-by":"publisher","first-page":"1141355","DOI":"10.3389\/fmed.2023.1141355","volume":"10","author":"P Angoorani","year":"2023","unstructured":"Angoorani P, Ejtahed H-S, Ettehad Marvasti F, Taghavi M, Mohammadpour Ahranjani B, Hasani-Ranjbar S, Larijani B (2023) The effects of probiotics, prebiotics, and synbiotics on polycystic ovarian syndrome: an overview of systematic reviews. Front Med 10:1141355","journal-title":"Front Med"},{"issue":"100752","key":"1577_CR3","doi-asserted-by":"publisher","first-page":"100752","DOI":"10.1016\/j.prmcm.2026.100752","volume":"18","author":"M Asaduzzaman","year":"2026","unstructured":"Asaduzzaman M, Nahar L, Biswas MS, Podder MK, Rahman MM (2026) Phyllanthus amarus as a multifunctional medicinal herb: Bioactive compounds, mechanisms, and clinical perspectives. Pharmacol Res - Mod Chin Med 18(100752):100752","journal-title":"Pharmacol Res - Mod Chin Med"},{"issue":"1632435","key":"1577_CR4","doi-asserted-by":"publisher","first-page":"1632435","DOI":"10.3389\/fmicb.2025.1632435","volume":"16","author":"J Bautista","year":"2025","unstructured":"Bautista J, Echeverr\u00eda CE, Maldonado-Noboa I, Ojeda-Mosquera S, Hidalgo-Tinoco C, L\u00f3pez-Cort\u00e9s A (2025) The human microbiome in clinical translation: from bench to bedside. Front Microbiol 16(1632435):1632435","journal-title":"Front Microbiol"},{"key":"1577_CR5","doi-asserted-by":"publisher","unstructured":"Beetch M, Akhaphong B, Wong A, Clifton B, Jo S, Mohan R, Llorens AJE, Alejandro EU (2023) Impact of placental mTOR deficiency on peripheral insulin signaling in adult mice offspring. J Mol Endocrinol 71(4). https:\/\/doi.org\/10.1530\/JME-23-0035","DOI":"10.1530\/JME-23-0035"},{"issue":"3","key":"1577_CR6","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"JYL Chiang","year":"2020","unstructured":"Chiang JYL, Ferrell JM (2020) Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol 318(3):G554\u2013G573","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"1577_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00404-024-07833-3","volume":"311","author":"I Chudzicka-Struga\u0142a","year":"2025","unstructured":"Chudzicka-Struga\u0142a I, Kubiak A, Banaszewska B, Wysocka E, Zwozdziak B, Siakowska M, Pawelczyk L, Duleba AJ (2025) Six-month randomized, placebo controlled trial of synbiotic supplementation in women with polycystic ovary syndrome undergoing lifestyle modifications. Arch Gynecol Obstet 311(2):499\u2013506","journal-title":"Arch Gynecol Obstet"},{"key":"1577_CR8","doi-asserted-by":"publisher","first-page":"578386","DOI":"10.3389\/fimmu.2021.578386","volume":"12","author":"F Cristofori","year":"2021","unstructured":"Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R (2021) Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: A door to the body. Front Immunol 12:578386","journal-title":"Front Immunol"},{"issue":"5","key":"1577_CR9","first-page":"671","volume":"36","author":"AA da Silva","year":"2020","unstructured":"da Silva AA, do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JE (2020) Role of hyperinsulinemia and insulin resistance in hypertension: Metabolic syndrome revisited. Can J Cardiol 36(5):671\u2013682","journal-title":"Can J Cardiol"},{"issue":"2","key":"1577_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F (2024) Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med 19(2):275\u2013293","journal-title":"Intern Emerg Med"},{"key":"1577_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coemr.2021.02.002","volume":"18","author":"S Franks","year":"2021","unstructured":"Franks S (2021) Androgen production and action in the ovary. Curr Opin Endocr Metabolic Res 18:48\u201353","journal-title":"Curr Opin Endocr Metabolic Res"},{"issue":"9","key":"1577_CR12","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/nu15092211","volume":"15","author":"W Fusco","year":"2023","unstructured":"Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, Lener E, Mele MC, Gasbarrini A, Collado MC, Cammarota G, Ianiro G (2023) Short-chain fatty-acid-producing bacteria: Key components of the human gut Microbiota. Nutrients 15(9):2211","journal-title":"Nutrients"},{"issue":"2","key":"1577_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s13205-020-02615-5","volume":"11","author":"S Gantait","year":"2021","unstructured":"Gantait S, Mahanta M, Bera S, Verma SK (2021) Advances in biotechnology of Emblica officinalis Gaertn. syn. Phyllanthus emblica L.: a nutraceuticals-rich fruit tree with multifaceted ethnomedicinal uses. 3 Biotech 11(2):62","journal-title":"3 Biotech"},{"issue":"100228","key":"1577_CR14","doi-asserted-by":"publisher","first-page":"100228","DOI":"10.1016\/j.endmts.2025.100228","volume":"17","author":"A Ghafari","year":"2025","unstructured":"Ghafari A, Maftoohi M, Samarin ME, Barani S, Banimohammad M, Samie R (2025) The last update on polycystic ovary syndrome(PCOS), diagnosis criteria, and novel treatment. Endocr Metabolic Sci 17(100228):100228","journal-title":"Endocr Metabolic Sci"},{"issue":"9","key":"1577_CR15","first-page":"746","volume":"11","author":"Y Guo","year":"2025","unstructured":"Guo Y, Ma C, Du L, Xu Y, Yang X (2025) Research progress on the application of food colloids in precise targeted delivery of drugs and bioactive compounds. Gels (Basel Switzerland) 11(9):746","journal-title":"Gels (Basel Switzerland)"},{"issue":"100291","key":"1577_CR16","doi-asserted-by":"publisher","first-page":"100291","DOI":"10.1016\/j.insi.2026.100291","volume":"2","author":"RY Halayal","year":"2026","unstructured":"Halayal RY, Bagewadi ZK, Patil VS, Kumbar PB, Yaraguppi DA, Mulla SI (2026) HR-LCMS metabolic profiling from Kalanchoe pinnata for tumor suppression and therapeutic bioactivities by in-vitro and integrated network pharmacology, molecular docking and dynamics simulations. Silico Res Biomed 2(100291):100291","journal-title":"Silico Res Biomed"},{"key":"1577_CR17","doi-asserted-by":"publisher","unstructured":"Han J, Manzoor M, Siddique R, Manzoor H, Moazzam S, Bazmi RR, Hussain L (2025) Pharmacological appraisal of Phyllanthus emblica in letrozole-induced polycystic ovarian syndrome female rats model. J Food Biochem 2025(1). https:\/\/doi.org\/10.1155\/jfbc\/8015756","DOI":"10.1155\/jfbc\/8015756"},{"issue":"17","key":"1577_CR18","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.3390\/ijms21176356","volume":"21","author":"J He","year":"2020","unstructured":"He J, Zhang P, Shen L, Niu L, Tan Y, Chen L, Zhao Y, Bai L, Hao X, Li X, Zhang S, Zhu L (2020) Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. Int J Mol Sci 21(17):6356","journal-title":"Int J Mol Sci"},{"issue":"204201882513830","key":"1577_CR19","doi-asserted-by":"publisher","first-page":"204201882513830","DOI":"10.1177\/20420188251383064","volume":"16","author":"BH Hoteit","year":"2025","unstructured":"Hoteit BH, Kotaich J, Ftouni H, Hazime F, Safawi A, Masri R, Marwani M (2025) The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials. Therapeutic Adv Endocrinol Metabolism 16(20420188251383064):20420188251383064","journal-title":"Therapeutic Adv Endocrinol Metabolism"},{"issue":"1","key":"1577_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12902-019-0486-9","volume":"20","author":"J Huang","year":"2020","unstructured":"Huang J, Liu L, Chen C, Gao Y (2020) PCOS without hyperandrogenism is associated with higher plasma Trimethylamine N-oxide levels. BMC Endocr Disorders 20(1):3","journal-title":"BMC Endocr Disorders"},{"issue":"10","key":"1577_CR21","first-page":"345","volume":"13","author":"K Kaur","year":"2025","unstructured":"Kaur K (2025) Application and challenges of using probiotic Lactobacillus and Bifidobacterium to enhance overall health and manage diseases. Dis (Basel Switzerland) 13(10):345","journal-title":"Dis (Basel Switzerland)"},{"issue":"16","key":"1577_CR22","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.3390\/ijms26167753","volume":"26","author":"E Kovacs","year":"2025","unstructured":"Kovacs E, Szabo K, Varvara R-A, Uif\u00e3lean A, Cozma A, Vulturar R, Sitar-Taut AV, Gabbianelli R, Myhrstad MCW, Telle-Hansen VH, Or\u00e3\u0219an OH, Fodor A, Suharoschi R, Heghe\u0219 S-C (2025) Resistant starch and Microbiota-derived secondary metabolites: A focus on postbiotic pathways in gut health and irritable bowel syndrome. Int J Mol Sci 26(16):7753","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1577_CR23","doi-asserted-by":"publisher","first-page":"7941857","DOI":"10.1155\/sci5\/7941857","volume":"2025","author":"SA Kuddus","year":"2025","unstructured":"Kuddus SA, Shohag MH, Yaseen QI, Ahmed L, Kashfia AT, Islam FB, Khan SI, Karim R, Hossain MM, Alam MA, Khan F (2025) The constituents of Phyllanthus emblica fruit ameliorate hyperlipidemia through the modulation of SREBPs, HMG-CoA reductase, and LDL receptor pathway. Scientifica 2025(1):7941857","journal-title":"Scientifica"},{"issue":"3","key":"1577_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.20517\/mrr.2025.35","volume":"4","author":"DH Lee","year":"2025","unstructured":"Lee DH, Seong H, Kim S-A, Han NS (2025) Synbiotic modulation of adult gut microbiome by 2\u2019-fucosyllactose and Bifidobacterium longum subsp. infantis EFEL8008. Microbiome Res Rep 4(3):26","journal-title":"Microbiome Res Rep"},{"issue":"104842","key":"1577_CR25","doi-asserted-by":"publisher","first-page":"104842","DOI":"10.1016\/j.etap.2025.104842","volume":"120","author":"A Lemogne Robert","year":"2025","unstructured":"Lemogne Robert A, Oliveira Torres E, Jota Baptista C (2025) Effects of endocrine disruptive chemicals (EDCs) and therapeutic approaches to the polycystic ovary syndrome (PCOS): A current state-of-the-art. Environ Toxicol Pharmacol 120(104842):104842","journal-title":"Environ Toxicol Pharmacol"},{"issue":"6","key":"1577_CR26","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/biomedicines10061250","volume":"10","author":"D Liu","year":"2022","unstructured":"Liu D, Zhong Z, Karin M (2022a) NF-\u03baB: A double-edged sword controlling inflammation. Biomedicines 10(6):1250","journal-title":"Biomedicines"},{"issue":"Suppl 3","key":"1577_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12859-022-04941-2","volume":"23","author":"Q Liu","year":"2022","unstructured":"Liu Q, Lee B, Xie L (2022b) Small molecule modulation of microbiota: a systems pharmacology perspective. BMC Bioinformatics 23(Suppl 3):403","journal-title":"BMC Bioinformatics"},{"issue":"8","key":"1577_CR28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun S-C (2025) NF-\u03baB in inflammation and cancer. Cell Mol Immunol 22(8):811\u2013839","journal-title":"Cell Mol Immunol"},{"issue":"22","key":"1577_CR29","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.3390\/nu16223916","volume":"16","author":"D Martinez Guevara","year":"2024","unstructured":"Martinez Guevara D, Vidal Ca\u00f1as S, Palacios I, G\u00f3mez A, Estrada M, Gallego J, Liscano Y (2024) Effectiveness of probiotics, prebiotics, and synbiotics in managing insulin resistance and hormonal imbalance in women with polycystic ovary syndrome (PCOS): A systematic review of randomized clinical trials. Nutrients 16(22):3916","journal-title":"Nutrients"},{"issue":"106840","key":"1577_CR30","doi-asserted-by":"publisher","first-page":"106840","DOI":"10.1016\/j.jsbmb.2025.106840","volume":"254","author":"D Muthukumaran","year":"2025","unstructured":"Muthukumaran D, Kumar J, Shanmugam R (2025) Inducing agents and PCOS - A comprehensive analysis. J Steroid Biochem Mol Biol 254(106840):106840","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"1577_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12263-024-00743-8","volume":"19","author":"M Nemati","year":"2024","unstructured":"Nemati M, Ebrahimi B, Montazeri-Najafabady N (2024) Probiotics ameliorate endocrine disorders via modulating inflammatory pathways: a systematic review. Genes Nutr 19(1):7","journal-title":"Genes Nutr"},{"issue":"1646382","key":"1577_CR32","doi-asserted-by":"publisher","first-page":"1646382","DOI":"10.3389\/froh.2025.1646382","volume":"6","author":"M Nireeksha","year":"2025","unstructured":"Nireeksha M, Luke A, Kumari N, Hegde S, M. N., Hegde NN (2025) Metabolic interplay of SCFA\u2019s in the gut and oral microbiome: a link to health and disease. Front Oral Health 6(1646382):1646382","journal-title":"Front Oral Health"},{"key":"1577_CR33","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3389\/fimmu.2020.01387","volume":"11","author":"C Peng","year":"2020","unstructured":"Peng C, Ouyang Y, Lu N, Li N (2020) The NF-\u03baB signaling pathway, the Microbiota, and gastrointestinal tumorigenesis: Recent advances. Front Immunol 11:1387","journal-title":"Front Immunol"},{"issue":"2","key":"1577_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5001\/omj.2010.24","volume":"25","author":"AK Philip","year":"2010","unstructured":"Philip AK, Philip B (2010) Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J 25(2):79\u201387","journal-title":"Oman Med J"},{"issue":"1","key":"1577_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/nu14010137","volume":"14","author":"D Plamada","year":"2021","unstructured":"Plamada D, Vodnar DC (2021) Polyphenols-gut Microbiota interrelationship: A transition to a new generation of prebiotics. Nutrients 14(1):137","journal-title":"Nutrients"},{"issue":"1669716","key":"1577_CR36","doi-asserted-by":"publisher","first-page":"1669716","DOI":"10.3389\/fendo.2025.1669716","volume":"16","author":"S Prosperi","year":"2025","unstructured":"Prosperi S, Chiarelli F (2025) Insulin resistance, metabolic syndrome and polycystic ovaries: an intriguing conundrum. Front Endocrinol 16(1669716):1669716","journal-title":"Front Endocrinol"},{"issue":"1700191","key":"1577_CR37","doi-asserted-by":"publisher","first-page":"1700191","DOI":"10.3389\/fendo.2025.1700191","volume":"16","author":"S Qin","year":"2025","unstructured":"Qin S, Guo S, Tan X, Li K, Huang J (2025) Research progress of gut microbiota and its metabolites in polycystic ovary syndrome. Front Endocrinol 16(1700191):1700191","journal-title":"Front Endocrinol"},{"issue":"4","key":"1577_CR38","first-page":"360","volume":"36","author":"S Rahman","year":"2023","unstructured":"Rahman S, O\u2019Connor AL, Becker SL, Patel RK, Martindale RG, Tsikitis VL (2023) Gut microbial metabolites and its impact on human health. Annals Gastroenterol 36(4):360\u2013368","journal-title":"Annals Gastroenterol"},{"issue":"17","key":"1577_CR39","doi-asserted-by":"publisher","first-page":"8658","DOI":"10.3390\/ijms26178658","volume":"26","author":"NC Rubas","year":"2025","unstructured":"Rubas NC, Torres A, Maunakea AK (2025) The gut microbiome and epigenomic reprogramming: Mechanisms, interactions, and implications for human health and disease. Int J Mol Sci 26(17):8658","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1577_CR40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4103\/aam.aam_164_23","volume":"23","author":"SV Rupashri","year":"2024","unstructured":"Rupashri SV, Selvaganesh S, Eahwaramoorthy R, Nesappan T (2024) Herbal Formulation of High Phenols and Flavonoids with the Extract of Phyllanthus emblica, Punica granatum, and Illicium verum and Assessment of Hematotoxicity Assay: An In vitro Study. Ann Afr Med 23(3):437\u2013442","journal-title":"Ann Afr Med"},{"issue":"100139","key":"1577_CR41","doi-asserted-by":"publisher","first-page":"100139","DOI":"10.1016\/j.medmic.2025.100139","volume":"25","author":"P Sankarganesh","year":"2025","unstructured":"Sankarganesh P, Bhunia A, Ganesh Kumar A, Babu AS, Gopukumar ST, Lokesh E (2025) Short-chain fatty acids (SCFAs) in gut health: Implications for drug metabolism and therapeutics. Med Microecology 25(100139):100139","journal-title":"Med Microecology"},{"key":"1577_CR42","doi-asserted-by":"crossref","unstructured":"Saravanan M, K A, P ASU, Sekar D (2024) Identification and expression of microRNA-34a-3p and its target Rapamycin-insensitive companion of mTOR (RICTOR) in polycystic ovarian syndrome in South Indian population. Acta Marisiensis - Seria Med 70(3):163\u2013168","DOI":"10.2478\/amma-2024-0025"},{"issue":"1","key":"1577_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15698\/cst2021.01.239","volume":"5","author":"H Shen","year":"2021","unstructured":"Shen H, Ding L, Baig M, Tian J, Wang Y, Huang W (2021) Improving glucose and lipids metabolism: drug development based on bile acid related targets. Cell Stress 5(1):1\u201318","journal-title":"Cell Stress"},{"issue":"5","key":"1577_CR44","doi-asserted-by":"publisher","first-page":"e70168","DOI":"10.1002\/mco2.70168","volume":"6","author":"Y Shen","year":"2025","unstructured":"Shen Y, Fan N, Ma S-X, Cheng X, Yang X, Wang G (2025) Gut Microbiota dysbiosis: Pathogenesis, diseases, prevention, and therapy. MedComm 6(5):e70168","journal-title":"MedComm"},{"key":"1577_CR55","doi-asserted-by":"publisher","unstructured":"Sivalingam AM, Pandian A (2024) Characterization of silver nanoparticles (AgNPs) synthesized using polyphenolic compounds from Phyllanthus emblica L. and their impact on cytotoxicity in human cell lines. Carbohydr Polym Technol Appl 8:100535. https:\/\/doi.org\/10.1016\/j.carpta.2024.100535","DOI":"10.1016\/j.carpta.2024.100535"},{"key":"1577_CR45","doi-asserted-by":"publisher","first-page":"1142041","DOI":"10.3389\/fcimb.2023.1142041","volume":"13","author":"Y Sun","year":"2023","unstructured":"Sun Y, Gao S, Ye C, Zhao W (2023) Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications. Front Cell Infect Microbiol 13:1142041","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1577_CR46","doi-asserted-by":"publisher","first-page":"42649","DOI":"10.1038\/s41598-025-26718-2","volume":"15","author":"P Szkodziak","year":"2025","unstructured":"Szkodziak P, Szkodziak F, Trzeciak K, Wo\u017aniak S, Mlynarczyk M, Paszkowski T (2025) Insulin resistance in polycystic ovary syndrome phenotypes and the vicious cycle model in its etiology. Sci Rep 15(1):42649","journal-title":"Sci Rep"},{"issue":"8","key":"1577_CR47","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.dsx.2022.102581","volume":"16","author":"DL Tahapary","year":"2022","unstructured":"Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, Rizka A, Tarigan TJE, Harbuwono DS, Purnamasari D, Soewondo P (2022) Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride\/glucose index. Diabetes Metabolic Syndrome 16(8):102581","journal-title":"Diabetes Metabolic Syndrome"},{"issue":"3","key":"1577_CR48","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/microorganisms13030611","volume":"13","author":"G Tiwana","year":"2025","unstructured":"Tiwana G, Cock IE, Cheesman MJ (2025) Phyllanthus emblica: Phytochemistry, antimicrobial potential with antibiotic enhancement, and toxicity insights. Microorganisms 13(3):611","journal-title":"Microorganisms"},{"issue":"1","key":"1577_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/toxics8010019","volume":"8","author":"P Tu","year":"2020","unstructured":"Tu P, Chi L, Bodnar W, Zhang Z, Gao B, Bian X, Stewart J, Fry R, Lu K (2020) Gut microbiome toxicity: Connecting the environment and gut microbiome-associated diseases. Toxics 8(1):19","journal-title":"Toxics"},{"issue":"1","key":"1577_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev-food-061120-014739","volume":"12","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Zhai Q, Zhang H, Chen W, Hill C (2021) Gut colonization mechanisms of Lactobacillus and Bifidobacterium: An argument for personalized designs. Annual Rev Food Sci Technol 12(1):213\u2013233","journal-title":"Annual Rev Food Sci Technol"},{"key":"1577_CR51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJWH.S344542","volume":"14","author":"C Xing","year":"2022","unstructured":"Xing C, Zhang J, Zhao H, He B (2022) Effect of sex hormone-binding globulin on polycystic ovary syndrome: Mechanisms, manifestations, genetics, and treatment. Int J Women\u2019s Health 14:91\u2013105","journal-title":"Int J Women\u2019s Health"},{"issue":"21","key":"1577_CR52","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.3390\/nu15214631","volume":"15","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Bonfili L, Wei T, Eleuteri AM (2023) Understanding the gut-brain axis and its therapeutic implications for neurodegenerative disorders. Nutrients 15(21):4631","journal-title":"Nutrients"},{"issue":"1","key":"1577_CR53","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, Gao J (2024) Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Therapy 9(1):234","journal-title":"Signal Transduct Target Therapy"},{"key":"1577_CR54","doi-asserted-by":"publisher","first-page":"1659783","DOI":"10.3389\/fmicb.2025.1659783","volume":"16","author":"S Zhu","year":"2025","unstructured":"Zhu S, Chen H, He B, Zhang Y, Li P, Kuang J (2025) Gut microbiota dysbiosis in polycystic ovary syndrome: focus on diet, probiotics, and traditional Chinese medicine. Front Microbiol 16:1659783","journal-title":"Front Microbiol"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01577-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-026-01577-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01577-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T18:02:33Z","timestamp":1787421753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-026-01577-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":55,"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1007\/s12223-026-01577-0","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have nothing to report.","order":1,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}